Singh takes on the role in addition to his current position as head of science and lab solutions commercial, India.
Effective April 1, Singh has taken over from Sreenath NS, who is retiring after 36 years of working with Merck in India.
“Dhananjay has played a key role in shaping the science and lab solutions commercial business in India. His experience in market dynamics and multi-stakeholder relationship management will strengthen Merck Life Science’s position in the Indian market,” Pratima Reddy, country speaker, Merck India, said in a statement.
In his role as the managing director, Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance alongside other leaders from Merck’s businesses in India. He joined Sigma-Aldrich in 1997. Over the years he took on several leadership roles in commercial organisations before his appointment as head of science and lab solutions commercial for India, a position he held since 2022.
“Merck Life Science is committed to meeting customers’ demands through strategic focus on ‘India for India and India for the Globe’, aligned with our country strategy, our partnerships with customers and our team. Together, we will be able to navigate the landscape of the life sciences industry in India, supporting government initiatives like ‘Make in India’ to foster growth and innovation,” said Singh on his appointment.Merck operates across life science, healthcare and electronics, and generated sales of €21 billion in 65 countries last year.
